Aprea Therapeutics Inc (APRE) — Strategic Asset Allocation Index
Aprea Therapeutics Inc (APRE) has a Strategic Asset Allocation Index of 0.0% as of June 2023. Strategic assets (PP&E of $1.69K plus long-term investments of $-) total $1.69K, measured against net assets of $23.42 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are Aprea Therapeutics Inc's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Aprea Therapeutics Inc Strategic Asset Allocation Index (2019–2022)
This chart shows how Aprea Therapeutics Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 0.0%, representing strategic assets of $1.69K against net assets of $23.42 Million USD. See Aprea Therapeutics Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Aprea Therapeutics Inc (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Aprea Therapeutics Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Aprea Therapeutics Inc worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | $2.32K | $2.32K | $- | $25.64 Million | ▼ -0.4 pp |
| 2021 | 0.4% | $209.68K | $209.68K | $- | $49.51 Million | ▼ 0.0 pp |
| 2020 | 0.5% | $359.13K | $359.13K | $- | $77.40 Million | ▲ +0.0 pp |
| 2019 | 0.5% | $563.03K | $563.03K | $- | $124.24 Million | — |